Mainz Biomed B.V. (MYNZ): Price and Financial Metrics
MYNZ Price/Volume Stats
Current price | $6.20 | 52-week high | $45.60 |
Prev. close | $6.00 | 52-week low | $3.65 |
Day low | $6.20 | Volume | 732 |
Day high | $6.20 | Avg. volume | 241,298 |
50-day MA | $5.48 | Dividend yield | N/A |
200-day MA | $13.30 | Market Cap | 12.41M |
MYNZ Stock Price Chart Interactive Chart >
Mainz Biomed B.V. (MYNZ) Company Bio
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic tests for clinical diagnostics in the area of human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, an early-stage molecular lateral-flow test; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
MYNZ Price Returns
1-mo | N/A |
3-mo | -27.02% |
6-mo | -56.82% |
1-year | -84.65% |
3-year | -99.02% |
5-year | N/A |
YTD | 43.52% |
2024 | -90.69% |
2023 | -83.66% |
2022 | -31.67% |
2021 | N/A |
2020 | N/A |
Loading social stream, please wait...